13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q1 2024 · Filed May 8, 2024 · Accession 0001104659-24-058588
Total Value
$8.1M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,534,220 | $4.2M | 51.67% |
| 2 | Spruce Bioscience, Inc. | SPRB | 2,936,281 | $2.3M | 28.35% |
| 3 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $1.6M | 19.12% |
| 4 | Vapotherm, Inc. | 922107107 | 52,881 | $69,806 | 0.86% |